←Back to Expert Scholars
Translational Medicine / 转化医学Milestone Hematology, CML and Transplant
John Goldman
MD, DM, FRCP
🏢Imperial College London / Hammersmith Hospital (Historical)🌐United Kingdom
Professor of Haematology (Historical)
120
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
John Goldman (deceased 2013) was a founding figure of modern CML therapy and allogeneic transplantation for CML at Hammersmith Hospital. He led early imatinib trials and molecular monitoring standards. He chaired EBMT and transformed CML treatment globally.
Share:
🧪Research Fields 研究领域
chronic myeloid leukemia
allogeneic transplant CML
imatinib trials
molecular MRD CML
EBMT leadership
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 John Goldman 的研究动态
Follow John Goldman's research updates
留下邮箱，当我们发布与 John Goldman（Imperial College London / Hammersmith Hospital (Historical)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment